CSL Plasma

CSL Vifor

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies.

Today, CSL – including our businesses, CSL Behring, CSL Seqirus, CSL Plasma and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest.

See our community guidelines: https://bit.ly/3Bs17Ra

CEO and Managing Director Paul McKenzie speaks to the outlook for CSL.  A recording of the half year earnings webcast can be found at our investor center:  https://bit.ly/48vgIhb #CSL 

CSL's CEO and Managing Director Paul McKenzie summarizes our financial performance for the first half of FY2024.  More: https://bit.ly/42EUzvj 

We have just released our half year results for financial year 2024. Check out a snapshot below, or head to our investor center for more information. https://bit.ly/4bAsSaX 

CSL’s Head of Research & Development, Dr. Bill Mezzanotte, weighs in on how the AEGIS-II program has left a lasting impact on our organization. Read more: https://bit.ly/49zh3Aj 

Today, we announced top-line results from the Phase 3 AEGIS-II trial. Read more: https://bit.ly/3I0ZVaA #CSL

Today, on the International Day of Women and Girls in Science, we uplift and celebrate the phenomenal women and girls who innovate, discover and inspire in the field of science!  Your pursuits push boundaries and forge a future in which every dream is possible.

Explore career opportunities at CSL: https://bit.ly/42QWopj

#InternationalDayOfWomenAndGirlsInScience #PromisingFutures #CSL


Octapharma AG is a global biopharmaceutical company that specializes in the development and production of human proteins from human plasma and human cell lines.

Octapharma AG

Regeneron Pharmaceuticals Inc is a leading biotechnology company that focuses on the discovery, development, and commercialization of innovative medicines for serious diseases.

Regeneron Pharmaceuticals Inc

Grifols is a global healthcare company that specializes in the production of plasma-derived medicines, diagnostics systems, and hospital pharmacy products.

Grifols

Takeda Pharmaceutical is a multinational pharmaceutical company that focuses on research, development, and marketing of pharmaceutical drugs.

Takeda Pharmaceutical

Sonic Healthcare is a global healthcare company that provides laboratory and radiology services, pathology, and primary care medical centers.

Sonic Healthcare

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. It comprises CSL Behring, CSL Seqirus, and CSL Vifor, providing diverse offerings to ensure patients and people everywhere get the treatments they need.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 7, 2024 4:08 PM	60a021f8
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 7, 2024 4:08 PM	74faba1c
company summary	general
signals	general	Mar 7, 2024 4:08 PM	5242cce1
crunchbase trigger	general
crunchbase profile	general
li profile	general	Mar 7, 2024 4:08 PM	87c7aed1
translate crunchbase fundingrounds	general
peers	general	Mar 7, 2024 4:08 PM	aab03f8b
news basic	general	Mar 7, 2024 4:08 PM	6f04617e
bundesanzeiger	filings	Mar 7, 2024 4:08 PM	af08850b
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:CSL

CSL